Cargando…

SHMT2 regulates esophageal cancer cell progression and immune Escape by mediating m6A modification of c-myc

BACKGROUND: In recent years, the role of altered cellular metabolism in tumor progression has attracted widespread attention. Related metabolic enzymes have also been considered as potential cancer therapeutic targets. Serine hydroxymethyltransferase 2 (SHMT2) has been reported to be upregulated in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Zhe, Li, Yu, Cheng, Yao, Li, Shaomin, Liu, Shiyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629073/ https://www.ncbi.nlm.nih.gov/pubmed/37932821 http://dx.doi.org/10.1186/s13578-023-01148-7

Ejemplares similares

SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis
por: Anderson, Donald D., et al.
Publicado: (2009)

SHMT2 Induces Stemness and Progression of Head and Neck Cancer
por: Jin, Yanli, et al.
Publicado: (2022)

Understanding The Regulatory Role of USP32 and SHMT2 in The Progression of Gastric Cancer
por: Li, Jun, et al.
Publicado: (2023)

Metabolic control of BRISC-SHMT2 assembly regulates immune signaling
por: Walden, Miriam, et al.
Publicado: (2019)

SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression
por: Cui, Ximao, et al.
Publicado: (2022)

SHMT2 regulates serine metabolism to promote the progression and immunosuppression of papillary renal cell carcinoma
por: Kong, Weiyu, et al.
Publicado: (2022)

Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma
por: Luo, Lianxiang, et al.
Publicado: (2021)

Cancer proteome and metabolite changes linked to SHMT2
por: Tong, Jiefei, et al.
Publicado: (2020)

HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification
por: Yang, Zhi, et al.
Publicado: (2020)

Glycyrrhetinic acid restricts mitochondrial energy metabolism by targeting SHMT2
por: Jin, Xiuxiu, et al.
Publicado: (2022)

The Role of m(6)A Modification and m(6)A Regulators in Esophageal Cancer
por: Li, Yuekao, et al.
Publicado: (2022)

SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production
por: Dou, Changwei, et al.
Publicado: (2019)

Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation
por: Liu, Chunqi, et al.
Publicado: (2021)

ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma
por: Tang, Wenhui, et al.
Publicado: (2022)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

Silencing SHMT2 inhibits the progression of tongue squamous cell carcinoma through cell cycle regulation
por: Liao, Yan, et al.
Publicado: (2021)

Targeting RNA N(6)-methyladenosine modification: a precise weapon in overcoming tumor immune escape
por: Li, Wei, et al.
Publicado: (2022)

Decreased m6A Modification of CD34/CD276(B7-H3) Leads to Immune Escape in Colon Cancer
por: Zhou, Yiran, et al.
Publicado: (2021)

The loss of SHMT2 mediates 5-fluorouracil chemoresistance in colorectal cancer by upregulating autophagy
por: Chen, Jian, et al.
Publicado: (2021)

The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma
por: He, Cheng, et al.
Publicado: (2023)

SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia
por: García-Cañaveras, Juan C., et al.
Publicado: (2020)

Roles of Mitochondrial Serine Hydroxymethyltransferase 2 (SHMT2) in Human Carcinogenesis
por: Zeng, Yuanyuan, et al.
Publicado: (2021)

SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer
por: Jin, Meihua, et al.
Publicado: (2021)

METTL3-mediated m(6)A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway
por: Han, Hui, et al.
Publicado: (2021)

NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc
por: Meng, Sibo, et al.
Publicado: (2023)

Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer
por: Ma, Zhenchuan, et al.
Publicado: (2017)

The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression
por: Jin, Zhe, et al.
Publicado: (2023)

The crucial role of miR-126 on suppressing progression of esophageal cancer by targeting VEGF-A
por: Kong, Ranran, et al.
Publicado: (2016)

Recent advances of m(6)A methylation modification in esophageal squamous cell carcinoma
por: Zhang, Xiaoqing, et al.
Publicado: (2021)

m6A regulator-mediated methylation modification patterns and tumor microenvironment immune infiltration with prognostic analysis in esophageal cancer
por: Sheng, Gaohong, et al.
Publicado: (2023)

SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer
por: Komlósi, Viktor, et al.
Publicado: (2010)

Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2
por: Tramonti, Angela, et al.
Publicado: (2021)

FLOURY ENDOSPERM20 encoding SHMT4 is required for rice endosperm development
por: Yan, Mengyuan, et al.
Publicado: (2022)

Tumor Escape and Progression under Immune Pressure
por: Manjili, Masoud H., et al.
Publicado: (2012)

Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer
por: Wang, Huan, et al.
Publicado: (2020)

Genome-wide identification and expression analysis of serine hydroxymethyltransferase (SHMT) gene family in tomato (Solanum lycopersicum)
por: Liu, Zesheng, et al.
Publicado: (2022)

SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation
por: Paone, A, et al.
Publicado: (2014)

Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma
por: Woo, Chern Chiuh, et al.
Publicado: (2016)

Mice deficient in the Shmt2 gene have mitochondrial respiration defects and are embryonic lethal
por: Tani, Haruna, et al.
Publicado: (2018)

p38 predicts depression and poor outcome in esophageal cancer
por: Cheng, Yao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pj44irff2cv96oppu0l488db0o